Last updated: July 30, 2024
Sponsor: Al-Azhar University
Overall Status: Active - Recruiting
Phase
3
Condition
N/ATreatment
Paracetamol 10mg/kg
Dexmedetomidine 0.5 mic/kg
Tramadol 1mg/kg
Clinical Study ID
NCT06274333
RC.18.1.2024
Ages 20-50 Male
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Age from 20 - 50 years
ASA (The American Society of Anesthesiologists) I or II,
undergo percutaneous nephrolithotomy (PCNL)
Exclusion
Exclusion Criteria:
Patients with history of psychotic illnesses
Opioid users
Bladder obstruction,
Benign prostatic hyperplasia
Overactive bladder (OAB) defined as frequency _3 times at night or _8 times within 24 hours.
Study Design
Total Participants: 60
Treatment Group(s): 3
Primary Treatment: Paracetamol 10mg/kg
Phase: 3
Study Start date:
February 28, 2024
Estimated Completion Date:
November 30, 2024
Connect with a study center
Neveen Kohaf
Cairo, 11865
EgyptActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.